Johan Rojas Suspended 80 Games for PED Violation

Why this matters: Rojas' suspension impacts the Phillies' depth in center field and his potential role as a fallback option if other prospects don't perform well. It also raises questions about the use of performance-enhancing drugs in baseball.

Johan Rojas, the Philadelphia Phillies outfielder, faces an 80-game suspension due to a positive test for Boldenone, a performance-enhancing substance. The suspension was announced after an appeal filed by the players' association was denied.

Rojas, 25, has been the Phillies' center fielder for a significant portion of the past three seasons. While he is known for his defensive skills and base-stealing abilities, his offensive performance has been inconsistent. Since the start of 2024, he has a .237/.279/.312 batting line, which translates to a 64 wRC+, indicating he was 36% below the league average at the plate during that time.

Given his offensive struggles, the Phillies have been exploring other options in center field. They acquired Harrison Bader at last year's trade deadline, and they plan to give prospect Justin Crawford an opportunity to take over the position. Rojas could have started 2026 as a fourth outfielder or received regular playing time in the minor leagues. However, the suspension now removes him from consideration for the first half of the season. Even if he returns in the second half, Rojas will be ineligible for the postseason.

Without Rojas, the Phillies' center field depth is somewhat limited. Brandon Marsh, who typically plays left field, has experience in center field but may not be ideal defensively. Pedro León is on the 40-man roster but has only played seven major league games. Utility player Dylan Moore has some limited experience in center field and could be added to the roster as a multi-positional bench player. The Phillies may also look to add center field coverage as teams make their final roster decisions before Opening Day.

Boldenone, a performance-enhancing substance.

80 games.

At the beginning of the 2026 regular season.

No, players serving PED suspensions are ineligible for the postseason.

Johan Rojas' suspension highlights the ongoing issue of performance-enhancing drugs in baseball. For Phillies fans, it means the team will need to rely on other players to fill the center field position. Keep an eye on how the Phillies address their center field depth in the coming weeks as they prepare for the 2026 season.

What do you think about Johan Rojas' suspension? How will this impact the Phillies' season? Share this article with others who need to stay ahead of this trend!